Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue

Stem Cells and Development

Volumn 19, Issue 6, 2010, Pages 915-925

  Quirici, Nadia ^a   Scavullo, Cinzia ^a   De Girolamo, Laura ^b   Lopa, Silvia ^a   Arrigoni, Elena ^a   Deliliers, Giorgio Lambertenghi ^c   Brini, Anna T ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; CELL MARKER; LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR; LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADIPOSE TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE CELL; CELL PROLIFERATION; CELL SUBPOPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; EXTRACELLULAR MATRIX; FEMALE; GLYCOSAMINOGLYCANS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; RECEPTOR, NERVE GROWTH FACTOR; SUBCELLULAR FRACTIONS;

EID: 77954194019     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0408     Document Type: Article

References (65)

1. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Masrhak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
2. Zvaifl er NJ, L Marinova-Mutafchieva, G Adams, CJ Edwards, J Moss, JA Burger and RN Maini. (2000). Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2: 477-488.
3. Kuznetsov SA, MH Mankani, S Gronthos, K Satomura, P Bianco and PG Robey. (2001). Circulating skeletal stem cells. J Cell Biol 153: 1133-1140.
4. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrik. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
5. Erices A, P Conget and JJ Minguell. (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242.
6. Goodwin HS, AR Bicknese, SN Chien, BD Bogucki, CO Quinn and DA Wall. (2001). Multilineage differentiation activity by cell isolated from umbilical cord blood: expression of bone, fat, and neural markers. Blood Marrow Transplant 7: 581-588.
7. Bieback K, S Kern, H Klueter and H Eichler. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634.
8. Kogler G, S Sensken, JA Airey, T Trapp, M Mueschen, N Feldhan, S Liedtke, RV Sorg, J Fischer, C Rosenbaum, S Greschat, A Knipper, J Bender, O Degistirici, J Gao, AI Caplan, EJ Colletti, G Almeida Porada, HW Mueller, E Zanjani and P Wernet. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200: 123-135.
9. Jiang Y, B Vaessen, T Lenvik, M Blackstad, M Reyes and CM Verfaille. (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30: 896-904.
10. In't Anker PS, SA Scherjon, C Kleijburg-van der Keur, WA Noort, FH Claas, R Willemze, WE Fibbe and HH Kanhai. (2003). Amniotic fl uid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549.
11. Zuk PA, M Zhu, H Mizuno, J Huang, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.
12. Halvorsen YD, D Franklin, AL Bond, DC Hitt, C Auchter, AL Boskey, EP Paschalis, WO Wilkison and JM Gimble. (2001). Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 7: 729-741.
13. Erickson GR, JM Gimble, DM Franklin, HE Rice, H Awad and F Guilak. (2002). Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 290: 763-769.
14. Safford KM, KC Hicok, SD Safford, YD Halvorsen, WO Wilkison, JM Gimble and HE Rice. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 294: 371-379.
15. Mizuno H, PA Zuk, M Zhu, HP Lorenz, P Benhaim and MH Hedrick. (2002). Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 109: 199-209. (Pubitemid 34056677)
16. Ashjian PH, AS Elbarbary, B Edmonds, D DeUgarte, M Zhu, PA Zuk, HP Lorenz, P Benhaim and MH Hedrick. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111: 1922-1931.
17. Huang JI, PA Zuk, NF Jones, M Zhu, HP Lorenz, MH Hedrick and P Benhaim. (2004). Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg 113: 585-594.
18. Miranville A, C Heeschen, C Sengenes, CA Curat, R Busse and A Bouloumi. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 349-355.
19. Planat-Benard V, JS Silvestre, B Cousin, M Abdr, M Nibbelink, R Tamarat, M Clerque, C Manneville, C Saillan-Barreau, M Duriez, A Tedqui, B Levy, L Picaud and L Casteilla. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
20. Planat-Benard V, C Menard, M Andr, M Puceat, A Perez, JM Garcia-Verdugo, L Picaud and L Casteilla. (2004). Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94: 223-229.
21. Seo MJ, SY Suh, YC Bae and JS Jung. (2005). Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 328: 258-264.
22. Puissant B, C Barreau, P Bourin, C Clavel, J Corre, C Bousquet, C Taureau, B Cousin, M Abbal, P Laharrague, L Picaud, L Casteilla and A Blancher. (2005). Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129: 118-129.
23. McIntosh K, S Zvonic, S Garrett, JB Mitchell, ZE Floyd, L Hammill, A Kloster, Y Di Halvorsen, JP Ting, RW Storms, G Kilroy, X Wu and JM Gimble. (2006). The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24: 1246-1253.
24. Gimble JM and F Guilak. (2003). Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol 58: 137-160.
25. Fraser JK, I Wulur, Z Alfonso and MH Hedrick. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24: 150-154.
26. Yoshimura K, K Sato, N Aoi, M Kurita, T Hirohi and K Harii. (2008). Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesth Plast Surg 32: 48-55.
27. Yoshimura K, K Sato, N Aoi, M Kurita, K Inoue, H Suga, H Eto, H Kato, T Hirohi and K Harii. (2008). Cell-assisted lipotransfer for facial lipoatrophy: effi cacy of clinical use of adipose-derived stem cells. Dermatol Surg 34: 1178-1185.
28. Garcia-Olmo D, M Garc-Arranz, D Herreros, I Pascual, C Peiro and JA Rodriguez-Montes. (2005). A phase I clinical trial of the treatment of Crohn's fi stula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48: 1416-1423.
29. Garcia-Olmo D, D Herreros, I Pascual, JA Pascual, E Del-Valle, J Zorrilla, P De-La-Quintana, M Garcia-Arranz and M Pascual. (2009). Expanded adipose-derived stem cells for the treatment of complex perianal fi stula: a phase II clinical trial. Dis Colon Rectum 52: 79-86.
30. Schipper BM, KG Marra, W Zhang, AD Donnenberg and JP Rubin. (2008). Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 60: 538-544.
31. Van Harmelen V, K Rohrig and H Hauner. (2004). Comparison of proliferation and differentiation capacity of human adipose precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53: 632-637.
32. Sen A, YR Lea-Currie, D Sujkowska, DM Franklin, WO Wilkison, YD Halvorsen and JM Gimble. (2001). Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem 81: 312-319.
33. de Girolamo L, S Lopa, E Arrigoni, MF Sartori, FW Preis and AT Brini. (2009). Human adipose-derived stem cells isolated from young and elderly women: study on their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation. Cytotherapy 11: 793-803.
34. Quirici N, D Soligo, P Bossolasco, F Servida, C Lumini and G Lambertenghi Delililers. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30: 783-791.
35. Gronthos S, DM Franklin, HA Leddy, PG Robey, RW Storms and JM Gimble. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189: 54-63.
36. Mitchell JB, K McIntosh, S Zvonic, S Garrett, ZE Floyd, A Kloster, Y Di Halvorsen, RW Storms, B Goh, G Kilroy, X Wu and JM Gimble. (2006). Immunophenotype of human adiposederived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24: 376-385.
37. Castro-Malaspina H, RE Gay, G Resnick, N Kapoor, P Meyers, D Chiarieri, S McKenzie, HE Brozmeyer and MA Moore. (1980). Characterization of human bone marrow fi broblast colonyforming cells (CFU-F) and their progeny. Blood 56: 289-301.
38. DiGirolamo CM, D Stokes, D Colter, DG Phinney, R Class and DJ Prockop. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifi es samples with the greatest potential to propagate and differentiate. Br J Hematol 107: 275-281.
39. Stanford CM, PA Jacobson, ED Eanes, LA Lembke and RJ Midura. (1995). Rapidly forming apoptotic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
40. Guilak F, KE Lott, HA Awad, Q Cao, KC Hicok, B Fermor and JM Gimble. (2006). Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206: 229-237. (Pubitemid 41740736)
41. Barbosa I, S Garcia, V Barbier-Chassefie, JP Caruelle, I Martelly and D Papy-Garcia. (2003). Improved and simple micro assay for sulfated glycosaminoglycans quantifi cation in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13: 647-653.
42. Jaiswal N, SE Haynesworth, AI Caplan and SP Bruder. (1997). Osteogenic differentiation of purifi ed, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
43. Aust L, B Devlin, SJ Foster, YD Halvorsen, K Hicok, T du Laney, A Sen, GD Willingmyre and JM Gimble. (2004). Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6: 7-14. (Pubitemid 38325114)
44. Murphy JM, K Dixon, S Beck, D Fabian, A Feldman and F Barry. (2002). Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 46: 704-713.
45. Barry FP. (2003). Biology and clinical applications of mesenchymal stem cells. Birth Defects Res C Embryo Today 69: 250-256.
46. Jurgens WJ, MJ Oedayrajsingh-Varma, MN Helder, B Zandiehdoulabi, TE Schouten, DJ Kuik, MJ Ritt and FJ van Milligen. (2008). Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell Tissue Res 332: 415-426.
47. Yamamoto N, H Akamatsu, S Hasegawa, T Yamada, S Nakata, M Ohkuma, E Miyachi, T Marunouchi and K Matsunaga. (2007). Isolation of multipotent stem cells from mouse adipose tissue. J Dermatol Sci 48: 43-52.
48. Murray L, B Chen, A Galy, S Chen, R Tushinki, N Uchida, R Negrin, G Tricot, S Jagannath and D Vesole. (1995). Enrichment of human hematopoietic stem cell activity in the CD34+Thy1+Lin subpopulation from mobilized peripheral blood. Blood 85: 368-378.
49. Menichella G, M Lai, R Serafi ni, L Pierelli, M Vittori, M Ciarli, C Rumi, P Puggioni, G Scambia, S Sica and G Leone. (1999). Large volume leukapheresis for collecting hematopoietic progenitors: role of CD34+ precount in predicting successful collection. Int J Artif Organ 22: 334-341.
50. Lee JY, Z Qu-Petersen, B Cao, S Kimura, R Jankowski, J Cummins, A Usas, C Gates, P Robbins, A Weernig and J Huard. (2000). Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150: 1085-1100.
51. Garcia-Pacheco JM, C Oliver, M Kimatrai, FJ Bianco and EG Olivares. (2001). Human decidual stromal cells express CD34 and Stro-1 and are related to bone marrow stromal precursors. Mol Hum Reprod 7: 1151-1157.
52. Deans RJ and AB Moseley. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884.
53. Simmons PJ and B Torok-Storb. (1991). CD34 expression by stromal precursors in normal adult bone marrow. Blood 78: 2848-2853.
54. Civin CJ, ML Banquerigo, LC Strauss and MR Loken. (1987). Antigenic analysis of hematopoiesis. IV. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol 15: 10-17.
55. Simmons PJ and B Torok-Storb. (1991). Identifi cation of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78: 55-62.
56. Vinatier C, D Mrugala, C Jorgensen, J Guicheux and D Noel. (2009). Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 27: 307-314.
57. Jones EA, A English, K Henshaw, SE Kinsey, AF Markham, P Emery and D McGonagle. (2004). Enumeration and phenotypic characterization of synovial fl uid multipotential mesenchymal progenitor cells in infl ammatory and degenerative arthritis. Arthritis Rheum 50 (3): 817-827.
58. Sariola H, M Saarma, K Sainio, U Arum, J Palgi, A Vaahtokari, I Thesleff and A Karavanov. (1991). Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 254: 571-573.
59. Lee KF, E Li, LJ Huber, SC Landis, AH Sharpe, MV Chao and R Jaenish. (1992). Targeted mutation of the gene encoding the low affi nity NGF receptor p75 leads to defi cits in the peripheral sensory nervous system. Cell 69: 737-749.
60. Campagnolo L, MA Russo, A Puglianiello, A Favale and G Siracusa. (2001). Mesenchymal cell precursors of peritubular smooth muscle cells of the mouse testis can be identifi ed by the presence of the p75 neurotrophin receptor. Biol Reprod 64: 464-472.
61. Suzuki K, M Tanaka, N Watanabe, S Saito, H Nonaka and A Miyajima. (2008). p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fi broblasts in mouse fetal liver. Gastroenterology 135: 270-281.
62. Glass DJ, SH Nye, P Hantzopoulos, MJ Macchi, SP Squinto, M Goldfarb and GD Yancopoulos. (1991). TrB mediates BDNF/ NT-3-dependent survival and proliferation in fi broblast lacking the low affi nity NGF-receptor. Cell 66: 405-413.
63. Trim N, S Morgan, M Evans, R Issa, D Fine, S Afford, B Wilkins and J Iredale. (2000). Hepatic stellate cells express the low affi nity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol 156: 1235-1243.
64. Sengenes C, K Lolmede, A Zakaroff-Girard, R Busse and A Bouloumi. (2005). Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells. J Cell Physiol 205: 114-122.
65. Traktuev DO, S Merfeld-Clauss, J Li, M Kolonin, W Arap, R Pasqualini, BH Johnstone and KL March. (2008). A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102: 77-85.